REQUEST A DEMO
Total
USD $0.00
Search more companies

Sriprasit Pharma Company Limited (Thailand)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Sriprasit Pharma Company Limited Profile Updated: March 31, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Sriprasit Pharma Company Limited is based in Thailand. The head office is in Samut Sakhon. It operates in the Pharmaceutical Preparation Manufacturing sector. The company was established on May 15, 1975. It currently has a total number of 250 (estimated) employees. In 2024, the company reported a net sales revenue increase of 6.23%. A growth of 18.62% was recorded in its total assets. The net profit margin of Sriprasit Pharma Company Limited decreased by 0.59% in 2024.

Headquarters
216 Moo 6
Samut Sakhon; Central Thailand; Postal Code: 74110

Contact Details: Purchase the Sriprasit Pharma Company Limited report to view the information.

Basic Information
Total Employees:
Purchase the Sriprasit Pharma Company Limited report to view the information.
Financial Auditors:
Purchase the Sriprasit Pharma Company Limited report to view the information.
Incorporation Date:
May 15, 1975
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Managing Director
Company Performance
Financial values in the chart are available after Sriprasit Pharma Company Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency THB. Absolute financial data is included in the purchased report.
Net sales revenue
6.23%
Total Operating Revenue
6.11%
Operating Profit
4.14%
EBITDA
4.14%
Net Profit/Loss for the Period
4.16%
Total Assets
18.62%
Total Equity
22.01%
Operating Profit Margin
-0.59%
Net Profit Margin
-0.59%
Return on Equity (ROE)
-3.47%
Debt / Equity
-0.22%
Quick Ratio
1.77%
Cash Ratio
1.33%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?